GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled.

Slides:



Advertisements
Similar presentations
GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled.
Advertisements

Atlas Copco Group Q2 Results July 16, Contents  Q2 business highlights  Market development  Business areas  Financials  Outlook 2 July 16,
July 18, 2008, Atlas Copco Group Q2 Results July 18, 2008.
Atlas Copco Group Q4 Results February 2, Q4 - highlights  Order growth continued  Record operating profit –All business areas above 20% operating.
AGENDA  Cash flow  Balance sheet items  Currency effects  Quarterly earnings GETINGE GROUP.
GETINGE Acquisition of Boston Scientific’s Cardiac and Vascular Surgery Businesses.
GETINGE Acquisition of Datascope Corp.. 2 BUSINESS AREA INFECTION CONTROL HEALTHCARE Transaction Overview ____________________ (1)Exchange rate used for.
Acquisition of Jostra Group GETINGE has signed an agreement to purchase 100% of the shares of Jostra A.G. GETINGE will not acquire Jostra’s former US operations.
 Broad-based health care company that discovers, develops, manufactures, and markets products and services  Abbott's main businesses: ◦ Global pharmaceuticals.
November 10, 2009 By: Ron Sivick.  Current price: $61.94  52 week range: $  Market cap: 180B  Large Core, Classic Growth  Sector: Consumer.
Atlas Copco Group Q1 Results April 20, Q1 - highlights  Very strong order intake –Record orders received in all business areas  Record operating.
1. 2 “Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson.”
Exel Oyj Interim Report January – March
GETINGE Capital Markets Day January 30 th, GETINGE... a rapidly expanding healthcare company.
CMN – Ashneil Jain. Theses Points Leader in a Growing Industry Well Balanced Portfolio of Products Potential for Tremendous Growth.
February 2, Atlas Copco Group Q4 Results February 2, 2010.
GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control and care of elderly and disabled people CustomersAcute.
GETINGE GROUP GETINGE Capital Market Day February 1 st, 2006.
Getinge Group. Shaping Health Care of tomorrow Net Sales10.9 billion SEK INFECTION CONTROL Production units10 Sales companies25 EXTENDED CARE Production.
AXIS Communications - a world of intelligent networks Full year 2002 CEO Peter Ragnarsson CFO Jörgen Lindquist.
The SKF Group Half-year result, 2005 Tom Johnstone, President and CEO.
1 The world’s leading manufacturer of collagen products for the food industry 2008 Interim Results Presentation 28 August 2008.
Tetra Acquisition Presentation March Forward Looking Statements This presentation includes forward-looking statements, which are based in part on.
Atlas Copco Group Q3 Results October 22, Q3 - highlights  Strong order growth –Sequentially higher volumes in all regions and in most customer.
July 17, Atlas Copco Group Q2 Results July 17, 2006.
April 24, 2008, Atlas Copco Group Q1 Results April 24, 2008.
October 23, 2008, Atlas Copco Group Q3 Results October 23, 2008.
April 26, 2007, Atlas Copco Group Q1 Results April 26, 2007.
Irwin/McGraw-Hill ©The McGraw-Hill Companies,, Inc., 2000 Irwin/McGraw-Hill ©The McGraw-Hill Companies,, Inc., 2000 Irwin/McGraw-Hill ©The McGraw-Hill.
BUSINESS AREA INFECTION CONTROL HEALTHCARE GETINGE GROUP A G E N D A  Cash flow  Balance sheet items  Currency effects.
GETINGE CAPITAL MARKETS DAY Johan Malmquist, CEO Boston 31 st of January 2012.
Innovations in Food Industry
GETINGE GROUP Year end report January – December January 2012 Johan Malmquist, CEO Ulf Grunander, CFO.
Getinge overview An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly.
Business Growth & Expansion
1 A BUSINESS TRANSFORMED May Financial Highlights ▬Turnover up 76% to £6.91m (2005: £3.92m) ▬Operating profit up 30% to £1.00m (2005: £0.77m)
Ecolab --the company profile.
INTERNATIONAL MARKETING MANAGEMENT SESSION 13: GLOBAL PORTFOLIO STRATEGY 1.
Newell Rubbermaid Company Overview. 2  We are a global marketer of consumer and commercial products with a strong portfolio of leading brands known for.
Atlas Copco Group Q results January 30, 2014.
Atlas Copco Group Q2 Results July 18, Q2 - highlights  Very strong organic order growth –Record orders received –Favorable demand in mining, manufacturing.
Atlas Copco Group Q results October 25, 2013.
Atlas Copco Group Q3 Results October 23, Page 2 October 23, 2001www.atlascopco-group.com Contents  Market Development  Business Areas  Financials.
July 16, 2007, Atlas Copco Group Q2 Results July 16, 2007.
Atlas Copco Group Q3 Results October 21, Q3 - highlights  Overall demand remained at a high level –Solid development in manufacturing and mining.
Atlas Copco Group Q1 Results Stockholm, April 26, 2001.
COMMITTED TO SUSTAINABLE PRODUCTIVITY Q results April 29, 2014.
Group Handout Atlas Copco Group – September 30 th 2000 The face of interaction.
Giulio Mazzalupi Atlas Copco Group - Q4 Results Stockholm, February 12, 2001.
Atlas Copco Group Q1 Results April 28, Contents  Q1 Business Highlights  Market Development  Business Areas  Financials  Outlook.
Chapter 2 Strategic Training. Chapter 2 Internal Factors That Influence Training Work Roles of Different Employee Groups: Employee – Change from passive.
Industrial and Manufacturing Engineering JACLYN VANGILDER LAURA PAZ VINCENT ISOPI.
The SKF Group Half-year result 2003 Tom Johnstone President and CEO.
INTERNATIONAL MARKETING MANAGEMENT SESSION 13: GLOBAL PORTFOLIO STRATEGY 1.
Andy Passey September 23rd 2003 Advanced Wound Management in Europe: Market Overview and Critical Success Factors © 2003 Frost & Sullivan. All rights reserved.
Growth through investment. Introduction to Bibby Line Group Started as a family- owned shipping business on 1807 Group now includes logistics, financial.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by PL Market forecast to expand.
AddLife Year-end report February, 2017
Strategic Training.
Maquet in brief Net sales 99/ M EUR Employees 1 300
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Infection Control Market analysis.
Strategy formulation and implementation
Developing Business-Level Strategy Options
Strategy and Management Control system
International Strategy
Global Medical Device Market Report : Trends, Forecast and Competitive Analysis 1.
Atlas Copco Group Q3 Results October 22, 2010.
Hospital Expansion Planning – Achieving Growth Targets
Atlas Copco Group Q results October 24, 2012.
GETINGE GROUP Year end report January – December January 2012
Presentation transcript:

GETINGE An expanding Medical-Technology group with focus on comprehensive solutions for infection control, surgical systems and care of elderly and disabled people CustomersAcute Care Long term care Industry/Laboratories Net Salesappr. 7.5 billion SEK Associates5 500 Manufacturing20 production units in 8 countries Distribution100 sales companies in 26 countries Distributors in 100 countries

Infection Control Sterilisation Disinfection Industry Acute care Long term care Surgical Systems Surgical tables Surgical lamps Business Scope 2000 Extended Care Hygiene Systems Patient Handling Wound Care

Total Long term care Acute care Industry Western Europe North America Asia, Australia R O W 50 % 39 % 7 % 4 % 63 % 33 % 3 % 1 % 36 % 45 % 12 % 7 % 44 % 43 % 9 % 4 % Market Development 2000

Patient Handling Hygiene Systems Complete solutions for institutional extended care: Nursing Homes, Hospitals, Assisted Living Wound Care Extended Care

Hygiene SystemsPatient HandlingWound Care Market MSEK1 700 MSEK8 000 MSEK Growth % % % Getinge 55%Getinge 39%Hillrom US 25% Sakai JP 8% Sunrise US 12%KNCI US 20% Chiltern UK 4%Liko SE 7%Huntleigh UK 7% Guldman DK 5%Getinge 6% Extended Care

Från kostnad till intäkt Product leadership Positive outcomes Extended Care Strategic Corner-Stones Complete Solutions

Orders received (MSEK) Extended Care

Results (MSEK) Extended Care

DisinfectionIT-solutionsSterilization Infection Control - Health Care Load handling Complete Systems for: Central Processing Departments, Outpatient Surgery, Wards, Infectious Waste, Microbiology, Pharmacies

Load Handling Washin g Sterilization Water Treatment Complete Systems for: Production, Research / Laboratories, Animal Care Facilities, Food Industry Infection Control - Industry

Sterilization Disinfection Market MSEK2 500 MSEK Growth 4 %5 % Getinge 24% Getinge 27% Steris US 21%Miele DE 15% Sakura JP 8%Steris US 9% J & J US 7%Meiko DE 8% MMM DE 6%Bellimed CH 5% Fedegari IT 5% Infection Control

SterilizerDisinfector Load handling Logistics Information management Consumables After Sales service Education From Product to Solution CompleteInfectionControlSolutions From Cost to Revenue Infection Control Health Care

Från kostnad till intäkt Cost leadership Service Infrastructure Infection Control Strategic Corner-Stones Complete Solutions

Infection Control Orders received MSEK

Results (MSEK) Infection Control

The infection control market and the market for surgical systems is converging Getinge will become a more attractive and competent supplier to the healthcare industry The market for surgical systems is to a large extent a fragmented market with further opportunities for acquired growth Business Area Surgical Systems Reasons for Expansion into the Surgical Systems Market

Surgical tablesSurgical lights Ceiling Service Units Market: M2 000 M1 000 M Growth: 5%5% % Getinge 40%Getinge 20%Draeger DE 25% Miizuho JPN 18%Berchtold DE 20%Kreuzer DE 15% Steris US 15%Steris US 15%Getinge 6% Echman UK 7% Heraeus DE 15%Johnson Med 5% Surgical Systems market shares MSEK

To create o strong global player in the surgical field with world leadership position in: - Surgical tables - Surgical lights - Ceiling service units Distributed through own sales organisation in all major developed markets Business Area Surgical Systems A First Step Business Area Surgical Systems A First Step

Production Closure of Charleston plant (USA) - transfer to Orléans(FR) and Rastatt(DE) Integration of Maquet infection control production with Business Area Infection Control Co-ordination of table production between Orléans(FR) and Rastatt (DE) Distribution Merger of sales companies USA:Maquet + ALM + Getinge UK:Maquet + ALM France:Maqueet + ALM Italy:Maquet + ALM Germany:Maaquet + Getinge Cross Selling Divestiture of Ortho-Maquet Integration & Restructuring of Maquet and ALM Synergies

Cost synergies are estimated to generate savings of MSEK per annum within 2 years Cross-selling will enable Business Area Surgical Systems to grow faster than the industry during year 2 to 5 The divestiture of Ortho-Maquet will improve operating results by approx 75 MSEK Integration & Restructuring of Maquet & ALM Synergies

Continuous growth through acquisition principally lights and ceiling service units Evaluate new areas of interest in the surgical systems environment Develop strong cross selling capabilities Product innovation - IGS - Endoscopy - Integrated surgical workplaces Business Area Surgical Systems Growth Opportunities

Getinge Group Objectives To retain and develop world leadership position in prioritized business areas / business niches Growth in profit before tax of 15% over a business cycle Organic growth 5 % Internally generated cash flow to sustain an external growth rate of I0 %

Getinge Industrier Results (MSEK)

Balance Sheets (MSEK)